Colorectal Cancer Trial, Recruiting NCT05396560 Sponsor: University of Calgary Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05396560
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 74 years old or younger
  • People who have at least one risk factor for bowel cancer that would typically lead to a doctor recommending a colonoscopy, such as: a personal history of low-risk bowel polyps, a personal history of high-risk bowel polyps, or a family history of bowel cancer or polyps

Who may not be able to join:

  • People who have been diagnosed with acromegaly (a hormonal condition) or cystic fibrosis, or who work as a firefighter
  • People whose colonoscopy was recommended because of a positive stool blood test or a CT scan of the bowel
  • People who are known or suspected to carry a gene linked to a hereditary cancer syndrome
  • People who do not meet the medical requirements for having a colonoscopy at the trial site (confirm with trial site)
  • People who have had a colonoscopy within the last 30 months
  • People who are unable to give written consent or complete questionnaires due to a language barrier or any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robert Hilsden, MD PhD, University of Calgary

Phone: 403-592-5089

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Calgary
Registry
ClinicalTrials.gov
Start date
15 April 2022
Est. completion
15 April 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Advanced Colorectal Neoplasia (ACN) Prevalence; Fecal Immunochemical Test Sensitivity and Specificity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov